机译:KRAS和DAXX / ATRX基因突变与临床病理特征,晚期疾病和中国胰腺神经内分泌肿瘤患者的预后不良相关
Shanghai Jiao Tong Univ Sch Med Dept Pathol Ruijin Hosp Shanghai 200025 Peoples R China;
Shanghai Jiao Tong Univ Sch Med Shanghai Inst Digest Surg Ruijin Hosp Dept Surg Shanghai 200025;
Shanghai Jiao Tong Univ Sch Med Shanghai Inst Digest Surg Ruijin Hosp Dept Surg Shanghai 200025;
Shanghai Jiao Tong Univ Sch Med Shanghai Inst Digest Surg Ruijin Hosp Dept Surg Shanghai 200025;
Shanghai Jiao Tong Univ Sch Med Shanghai Inst Digest Surg Ruijin Hosp Dept Surg Shanghai 200025;
Shanghai Jiao Tong Univ Sch Med Shanghai Inst Digest Surg Ruijin Hosp Dept Surg Shanghai 200025;
Shanghai Jiao Tong Univ Sch Med Shanghai Inst Digest Surg Ruijin Hosp Dept Surg Shanghai 200025;
Shanghai Jiao Tong Univ Sch Med Shanghai Inst Digest Surg Ruijin Hosp Dept Surg Shanghai 200025;
Shanghai Jiao Tong Univ Sch Med Shanghai Inst Digest Surg Ruijin Hosp Dept Surg Shanghai 200025;
pancreatic neuroendocrine tumor; gene mutation; prognosis; KRAS; DAXX/ATRX;
机译:KRAS和DAXX / ATRX基因突变与中国胰腺神经内分泌肿瘤患者的临床病理特征,晚期疾病和不良预后相关
机译:KRAS和DAXX / ATRX基因突变与临床病理特征,晚期疾病和中国胰腺神经内分泌肿瘤患者的预后不良相关
机译:端粒的替代性延长和DAXX / ATRX表达的丧失可预测胰腺神经内分泌肿瘤患者的转移性疾病和较差的生存率
机译:单细胞水平晚期NSCLC患者EGFR激活突变的细胞内异质性
机译:配对框基因5作为功能性肿瘤抑制因子的表观遗传学鉴定与胃癌患者预后不良相关。
机译:KRAS和DAXX / ATRX基因突变与中国胰腺神经内分泌肿瘤患者的临床病理特征晚期疾病和不良预后相关
机译:Daxx / Atrx和Men1基因是胰腺神经内分泌肿瘤中的强预后标志物